BVS
Bioventus Inc. Class A Common StockRecent alerts on BVS
All signals →
SEC filing
BVS FDA Reclassifies Exogen to Class II, CMS Updates Billing Rules, Reiterates 2026 Guidance
11d ago
News
Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
14d ago
News
Encompass Health (EHC) Expands in Louisville With New Rehab Unit
14d ago
News
Compelling Reasons to Hold on to Cigna (CI) Stock for Now
14d ago
News
J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe
14d ago
News
Humana (HUM) Partners With UAB to Boost Care for MA Members
14d ago
News
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
14d ago
News
Merck (MRK) to Buy Private Ophthalmology Company EyeBio
14d ago
News
Bioventus outlines 2026 adjusted EPS of $0.75-$0.79 while reaffirming $600M-$610M revenue
27d ago
Insider trade
Sale by Michelle Mcmurry-Heath
80d ago
News
Bioventus outlines $600M–$610M 2026 sales target with accelerated investment in PNS, PRP, and ultrasonics
89d ago
SEC filing
BVS Reports $157.9M Q4 Revenue, $0.21 GAAP EPS, $0.24 Adjusted EPS, $38M Cash Flow, 2026 Guidance Outlook
89d ago
News
Bioventus Non-GAAP EPS of $0.24 beats by $0.02, revenue of $157.9M beats by $2.95M
89d ago
Short volume
Short volume 67% of volume (6.5σ)
168d ago
Get push alerts for BVS
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS